期刊文献+

组织芯片制备及在肝癌研究的应用 被引量:2

Manufacture of Tissue Microarray and the Applications in Hepatocellular Carcinoma Researches
下载PDF
导出
摘要 目的建立组织芯片的手工制备技术并探讨其用于肝癌研究的可行性。方法利用改进的腰穿针手工制作组织芯片,进行免疫组织化学、组织化学染色和常规H-E染色,将组织芯片和普通切片的免疫组织化学结果对比观察。结果各种染色切片上的组织芯片基本符合观察需求,组织芯片和普通切片免疫组织化学结果基本一致。结论组织芯片具有高通量、经济节约、可比性和重复性强的特点,为高效快速地进行科研和临床工作提供一个新的技术平台。手工制备组织芯片简单易行,费用低廉,易于推广。 Objective To construct a kind of tissue microarrays chip for applied in hepatocellular carcinoma researches. Methods Tissue microarrays chip were constructed manually with needles puncture in waxy matrix. Immunohistochemical, histochemical and haematoxylineosin staining were performed on the sections. The results were compared with normal sections stained by immunohistochemical. Results The cores on slides were well preserved and basically met the requirements of research. There were no significant differences between the results of tissue microarrays and normal sections that were stained by immunohistochemistry. Conclusion Tissue microarrays have characters of high-throughput, economy, comparability and representing. They provided a novel technical platform for carrying out researches and clinical routines effectively. Construction of tissue microarrays manually is an easy and effective method and is easy to apply.
出处 《福建医科大学学报》 2006年第5期517-519,共3页 Journal of Fujian Medical University
基金 教育部重点基金资助项目(205077) 福建省教育厅科研基金资助项目(JA04193)
关键词 组织芯片 免疫组织化学 组织化学 肝细胞癌 tissue microarrays immunohistochemistry histochemistry hepatocellular neoplasm
  • 相关文献

参考文献3

二级参考文献25

  • 1[1]Kononen J,Bubendorf L,Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens.Nat Med,1998,4:844
  • 2[2]Florell SR,Coffin CM,Holden JA et al. Preservation of RNA for functional genomic studies:a multidisciplinary tumor bank protocol.Mod Pathol,2001,14:116
  • 3[3]Ekins R,Chu FW.Microarrays:their origins and applications.Trends Biotechnol,1999,17:217
  • 4[4]Wooster R.Cancer classification with DNA microarrays in less more? Trends Genet,2000,16:327
  • 5[5]Moch H,Kononen T,Kallioniemi OP et al.Tissue microarrays:what will they bring to molecular and anatomic pathology? Adv Anat Pathol,2001,8:14
  • 6[6]Sallinen SL,Sallinen PK,Haapasalo HK et al.Identificatin of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.Cancer Res,2000,60:6617
  • 7[7]Richter J,Wagner U,Kononen J.High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.Am J Pathol,2000,157:787
  • 8[8]Barlund M,Monni O,Kononen J et al.Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.Cancer Res,2000,60:5340
  • 9[9]Gaiser T,Thorns C,Merz H et al.Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays.J Hematother Stem Cell Res, 2002,11:423
  • 10[10]Husson H,Carideo EG,Neuberg D et al.Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays.Blood,2002,99:282

共引文献100

同被引文献17

  • 1周泱,龚国忠.丙型肝炎病毒非结构蛋白质5A激活Survivin基因的表达[J].中华肝脏病杂志,2006,14(6):414-417. 被引量:3
  • 2Bamberger AM, Riethdoff L, Milde-Langosch K, et al. Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch, 1999, 434: 423-428.
  • 3Zaffaroni N, Pennati M, Daidone MG. Survivin as a target for new anticancer interventions. J Cell Mol Med, 2005, 9: 360-372.
  • 4Morinaga S, Nakamura Y, Ishiwa N, et al. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Oncol Rep, 2004, 12: 1189-1194.
  • 5Fields AC, Cotsonis G, Sexton D, et al. Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod Pathol, 2004, 17:1378-1385.
  • 6Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer, 2001, 91: 2026-2032.
  • 7Pertia A, Nikoleishvili D, Trsintsadze O, et al. Loss of p27(Kip Ⅰ) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer. Int Urol Nephrol, 2007, 39: 381- 387.
  • 8Fiorentino M, Altimari A, D'Errico A, et al. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res, 2000, 6: 3966-3972.
  • 9Ito Y, Matsuura N, Sakon M, et al. Expression and prognostic roles of the GI-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology, 1999, 30: 90-99.
  • 10Oshita T, Shigemasa K, Nagai N, et al. p27, cyclin E, and CDK2 expression in normal and cancerous endometrium. Int J Oncol, 2002, 21 : 737-743.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部